Pharmaceuticals

Equity ETFs

ETF Plays for a Divided Midterm Elections

By Max ChenOctober 22, 2018

Equity ETFs

Pharmaceutical ETFs Could Maintain Their Momentum

By Max ChenSeptember 6, 2018

New ETFs

Loncar Debuts ETF to Play China’s Biotech, Pharma Companies

By Max ChenAugust 15, 2018

Equity ETFs

Biotech ETFs Rally as Illumina Tops Q2 Expectations

By Max ChenJuly 31, 2018

Equity ETFs

July Could Be a Volatile Month for Pharma ETFs

By Max ChenJuly 3, 2018

Equity ETFs

Amazon ETFs Mostly Down After PillPack Acquisition

By Ben HernandezJune 28, 2018

Equity ETFs

6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’

By Max ChenMay 11, 2018

Alternative ETFs

Direxion Resuscitates Leveraged Pharmaceutical ETF

By Max ChenNovember 15, 2017

Equity ETFs

Biotech, Pharma ETFs Leave Pricing Drama Behind

By Max ChenSeptember 15, 2017

Equity ETFs

Drug Makers, Pharma ETFs Face a Tough Earnings Season

By Max ChenApril 24, 2017

Equity ETFs

Alternative ETF Options to Hedge Trump Risk on Obamacare

By Tom LydonMarch 7, 2017

Equity ETFs

Healthcare ETFs Are Latest Victim to Trump

By Max ChenJanuary 11, 2017

Equity ETFs

Rising Rates May Hurt Small-Cap Biotech ETF Valuations

By Max ChenDecember 23, 2016

Equity ETFs

Trump Bursts Biotech ETFs’ Bubble

By Max ChenDecember 7, 2016

Equity ETFs

Will Trump Make Biotech ETFs Great Again?

By Max ChenNovember 28, 2016

Equity ETFs

Biotech ETFs Unwind Political Risk After Trump Victory

By Max ChenNovember 11, 2016

Equity ETFs

ETF Winners and Losers of President-Elect Trump

By Max ChenNovember 9, 2016

Equity ETFs

Look to These Sector ETFs in Case of an Election Day Surprise

By Max ChenNovember 4, 2016